Delcath Systems
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCTH and other ETFs, options, and stocks.About DCTH
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO.
CEOGerard J. Michel
CEOGerard J. Michel
Employees96
Employees96
HeadquartersQueensbury, New York
HeadquartersQueensbury, New York
Founded1988
Founded1988
Employees96
Employees96
DCTH Key Statistics
Market cap355.96M
Market cap355.96M
Price-Earnings ratio1.21K
Price-Earnings ratio1.21K
Dividend yield—
Dividend yield—
Average volume608.94K
Average volume608.94K
High today$10.62
High today$10.62
Low today$9.95
Low today$9.95
Open price$10.41
Open price$10.41
Volume617.68K
Volume617.68K
52 Week high$18.23
52 Week high$18.23
52 Week low$8.12
52 Week low$8.12
Stock Snapshot
With a market cap of 355.96M, Delcath Systems(DCTH) trades at $10.08. The stock has a price-to-earnings ratio of 1205.81.
On 2025-12-16, Delcath Systems(DCTH) stock moved within a range of $9.95 to $10.62. With shares now at $10.08, the stock is trading +1.3% above its intraday low and -5.1% below the session's peak.
Trading volume for Delcath Systems(DCTH) stock has reached 617.68K, versus its average volume of 608.94K.
The stock's 52-week range extends from a low of $8.12 to a high of $18.23.
The stock's 52-week range extends from a low of $8.12 to a high of $18.23.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own DCTH. This list is generated using Robinhood data, and it’s not a recommendation.